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Edited by Patrick AloyAbstract The community of scientists interested in studying
intrinsically unstructured (or disordered) proteins has emerged
in recent years. What began as a controversial idea has become
an established phenomenon. The new, greater focus on proteins
that are in some way normally unstructured promises to provide
a greater understanding of protein function, particularly with re-
spect to protein–protein interactions. These regions also oﬀer
new possibilities into how interactions can be targeted by small
molecules.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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There are some enterprises in which a careful disorderliness is
the true method. – Herman Melville, Moby Dick
‘‘The protein must have denatured during the puriﬁcation
process’’, or comments like it have been denting the egos of
prospective structural biologists for decades. Often a few more
months of toil in the laboratory can turn a denatured protein
into one suitable for structural analysis. However, nearly every
structural biologist has a collection of proteins that – often
after years of trying – were summarily left in the dustbin,
sometimes with tragic consequences. Such was a case, so told
by Keith Dunker (Indiana University), for a young scientist
who burst into tears after hearing him present his arguments
for the role of intrinsically unstructured proteins (or IUPs) in
biology. Apparently her failure to purify and crystallize such
a protein was taken as a sign of her incompetence and had lead
to her dismissal.
The concept that large parts of the proteome simply do not
form a well deﬁned structure of the sort that structural biolo-
gists like best to study is now well established. Keith Dunker
has pointed out that the notion of natively disordered proteins
has been around since the 1960s or 1970s, and possibly as far
back as the 1930s (Dunker et al., personal communication),
where a certain hint at a role for disorder was suggested in
the functioning of antibodies (e.g. [1]). In the early 1970s, Rus-
sell Doolittle deduced that parts of ﬁbrinogen were simply*Corresponding author. Fax: +49 6221 387 8517.
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doi:10.1016/j.febslet.2008.02.027‘‘waving in the breeze’’ [2]. However, probably for the simple
reason that there were many other things to study – namely
the thousands of globular proteins or domains that were still
uncharacterized – it appears that most instances were treated
as curiosities, and largely forgotten.2. Disorder ascendant
For many decades molecular biology concentrated mostly
on studying the functional protein modules, cumulating in
the 1990s with the identiﬁcation of thousands of new protein
domains associated with critical functions in biology (e.g.
[3]). During the discovery process, it was often observed that
many sequence regions simply did not look like modular, do-
main-like units, but probably there was not generally the time
or inclination to study these further, and they were often dis-
missed as linkers, or domains to be characterized at a later
date.
It takes a lot of courage to challenge the established dogma.
In the case of disorder it takes a certain persistence to believe
in it. As the Bond ﬁlm cliche´ goes: once is happenstance, twice
is circumstance, but three times is enemy action. Similarly goes
the ‘‘rule of 3’’ of Vladimir Uversky (University of California,
Santa Cruz) regarding the study of unstructured proteins. The
rule is that one must see three convincing instances of this phe-
nomenon in order to believe it to be genuine, and worth inves-
tigating further.
By the late 1990s it was clear that IUPs not only existed, but
were very abundant and moreover played critical roles in bio-
logical processes. Some early studies on the genome [4,5] sug-
gested that there were many IUPs around, and key reviews,
such as that from Wright and Dyson [6], highlighted key func-
tional roles for disorder in such examples as the cAMP regu-
lated transcription factor CREB and the acidic activation
domains of p53. Since then many hundreds of papers have ap-
peared mentioning disorder in biological literature, and the
growth over time is impressive (Fig. 1).3. Variations on a disordered theme
IUPs are not of a single type. They are rather a spectrum,
ranging from totally unfolded, through molten globules and
proteins containing mobile folded segments, to fully folded
proteins with parts ﬂapping in the breeze. Good examples of
all these can be found in proteins involved in many key biolog-
ical processes. For instance, a-synuclein is essentially disor-
dered over its entire length (e.g. [7]), with diﬀerent regions
folding to perform various functions. The tumor suppressorblished by Elsevier B.V. All rights reserved.
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Fig. 1. Plot of the number of publications mentioning terms related to IUPs since the mid 1990s. The ﬁgure was generated using PubMed searches
for the following terms: natively unfolded protein (175 in total), intrinsically disordered protein (170), intrinsically unstructured protein (125),
‘‘intrinsic disorder’’ AND protein (69), natively disordered protein (58), ‘‘protein disorder’’ NOT blood (48), ‘‘native disorder’’ AND protein (4).
Note how substantially the total numbers diﬀer, highlighting a lack of terminology consensus in the ﬁeld (see text). These raw numbers include a
small number of false positives, especially in older publications, but fairly reﬂect the variation of usage for the protein structural context. Note
however that most of the earliest disorder prediction methods are not retrieved with any of these search terms, mainly reﬂecting a change in term
usage to include ‘‘native’’ and/or ‘‘intrinsic’’.
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play roles in oligomerisation and DNA binding (Fig. 2), but al-
most half of its sequence is apparently not folded (e.g. [8]) and
is used largely to interact with an abundance of interaction
partners. It is, moreover, not just the fraction of disorder that
varies across the known examples, but the way disorder man-
ifests itself. All of this suggests the need to get the vocabulary
of IUPs under more systematic control. Indeed, just how one
refers to disordered/unstructured/natively unfolded regions is
in need of standardization. Fortunately, the community has re-
cently engaged the Gene Ontology (GO) consortium to stan-
dardize the way the phenomenon is described and recorded
in the future.
3.1. How much disorderliness in the proteome?
Just how much of a proteome is unstructured? The recent
availability of accurate predictors of disorder allows quite
accurate estimates as to the fraction of typical proteomes that
are in some ways disordered. Disorder is present but compar-
atively rare in prokaryotes, occurring in about 3–18% of their
proteins. In contrast, between 20% and 50% of all eukaryotic
proteins have some disorder, and up to 17% of all eukaryotic
proteins are predicted to be entirely natively disordered [9].
These fractions would surprise anyone who was used to look-
ing into the database of known three-dimensional structures
(i.e. the PDB) for an idea of what proteins are generally like.
It is becoming clear that this set of proteins, or protein do-
mains oﬀers only a partial picture of the overall properties of
the proteome.
It is also becoming clear that the fraction of the proteome
that is disordered appears to correlate with notions of biolog-
ical complexity – humans have more than yeast and yeast have
more than bacteria [9]. This point agrees well with the kinds of
functions that IUPs perform. Most often IUPs play roles in
signaling, regulation or control events more prominent in high-er organisms – and only rarely do they appear to have a role in
housekeeping processes such as metabolism. In other words,
proteins in signaling pathways contain more disorder than
proteins involved in metabolic processes.
3.2. What are IUPs for?
Just what are these unstructured proteins or regions doing?
Very often they are sites of protein–protein interactions. Many
protein recognition events, for instance in signaling networks,
are mediated by binding to IUPs. Normally these regions are
recognized by globular domains, but occasionally (see Arf/
MDM2 below) one IUP region can apparently bind to an-
other. The majority of short, linear functional sites, including
post-translational modiﬁcations, targeting sequences, or bind-
ing sites for signaling domains like SH3, are found outside of
the globular part of the proteome [10,11]. There has been much
recent work on the hunt for new linear motifs, and many of the
approaches indeed explicitly look inside disordered, or non-
globular segments for motif candidates (e.g. [12,13]).
It is no surprise that much of the work to date on IUPs has
focused on critically important molecules that stymied more
traditional attempts at structural analysis. Foremost among
these is the tumor suppressor p53, which contains a mixture
of globular domains and long disordered regions, and many
binding events involve interactions with disordered segments
(e.g. [14]). Fig. 2 shows a summary of unstructured regions
and interaction sites in p53. a-Synuclein is another long known
example, being normally unfolded and thought to transition
into semi-folded states that are responsible for its association
with neurodegenerative diseases [7].
It is not just what IUPs are doing, but how they are doing it
that is quite revolutionary. For instance, there are now clear
examples of the same stretch of a protein adopting diﬀerent
conformations under diﬀerent circumstances. These include
the C-terminal portion of p53, which interacts with at least
Fig. 2. Intrinsically unstructured or disordered regions of the tumor suppressor p53 as predicted by IUPred [30] (top; the y-axis shows disorder
tendency, with the dashed line denoting a threshold for disorder) and annotated for functional sites (bottom) bound by other proteins (boxes) or
post-translationally modiﬁed (circles). Numbers before the events denote the positions in the human sequence, and binding partners are abbreviated
using standard gene names. NES denotes the location of a nuclear export signal. Modiﬁcations and binding events were extracted from the ELM [10]
and Phospho.ELM [36] databases. The network below shows 412 interactions partners for p53 (TP53 in the center); those responsible for the
modiﬁcation and binding events shown above are in blue (interactions and image drawn using ToxWiz, Cambridge Cell Networks Ltd., UK).
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tions [15]. Elsewhere, it appears that interactions can be med-
iated without any globularity at all. For example, the bindingof MDM2/HDM2 to the protein Arf appears to occur when
two IUP segments from each protein come together; i.e. nei-
ther partner is ordered on its own [16]. All of these oddities call
1274 R.B. Russell, T.J. Gibson / FEBS Letters 582 (2008) 1271–1275into question some basic assumptions that people have made
about the way proteins operate. The protein-structure–func-
tion paradigm is clearly only applicable some of the time. Else-
where one must consider the possibility that a natively
disordered state plays an important role, and just what struc-
ture is adopted can vary according to cellular context.
One of the most remarkable disordered structures presented
recently is the WAT anchor module of the acetylcholinesterase
(AChE) enzyme associating with the PRAD attachment do-
main of Collagen Q [17]. Both components are natively disor-
dered and assemble by mutual ﬁt into a complex of 4 WAT
coiled coils wrapped around a single PRAD polyproline type
II helix. This complex associates with remarkably high aﬃnity
for such small peptide elements, even though the 4:1 stoichi-
ometry should not be possible with a PPII helix (periodicity
3.4 in PRAD): in fact there is a phase reset in the left-handed
superhelix formed by the WAT helices. The WAT/PRAD com-
plex anchors the widely distributed enzyme AChE at choliner-
gic synapses and it is likely that there are other comparable
anchoring systems to be discovered that position extracellular
proteins in key tissue locations.
Other recent examples include the protein CBP, a large
highly modular hub protein acting as a general transcriptional
coactivator. Among its 400 reported interaction partners are
chromatin remodelling machines and transcriptional com-
plexes including components which regulate genes induced
by hypoxia and associated signaling cascades. Structures for
most of the globular domains in CBP have been solved and
are starting to reveal regulatory mechanisms involving IUP
interactions. Natively disordered segments of hypoxia tran-
scription factor HIF-1a and hypoxia regulator CITED2 bind
by induced ﬁt in a deep surface groove of the CBP TAZ1 do-
main [18]. The two interaction surfaces overlap and binding is
therefore mutually exclusive and possibly competitive, creating
a transcriptional switch and a negative feedback loop in hy-
poxia signalling. Natively disordered activation modules of
c-Myb and MLL bind to a grooved surface of the CBP KIX
domain [19]. In this case the grooves are on opposite sides of
the domain but allosteric rearrangements of KIX surface loops
result in a cooperative increase in binding aﬃnity, aiding stable
transcriptional complex formation. Thus highly modular pro-
tein components and interactions with natively disordered
partners allow a single protein to operate independent positive
and negative regulatory controls in transcription. As CBP be-
comes better understood, more regulatory interactions involv-
ing multiple IUP partners should be revealed. More generally,
we may expect to see many more positive and negative regula-
tory interactions involving globular domains interacting with
multiple induced ﬁt IUP segments as signalling complexes
are better dissected.4. Studying IUPs and their (mis)behaviour
The very nature of these proteins means that one must take a
multidisciplinary approach to study them. As the story of the
failure to purify an IUP above suggests, such proteins do not
normally lend themselves to study by the traditional structural
approaches of X-ray crystallography or atomic level nuclear
magnetic resonance (NMR). However, since NMR can be
used to study protein folding or solution conformations, it is
often used as a tool for studying disorder. These types of
NMR studies and circular dichroism (CD) are the main work-
horses for studying IUP, complemented by innovative and
newer techniques, such as Raman optical activity (ROA; e.g.
[20]), or spin-labeling, in-cell NMR and others. Although it
is often not possible to see precisely what these proteins or re-gions look like, we now have a clearer picture of how IUPs be-
have biophysically, and how they perform speciﬁc functions.
Studies have revealed diﬀerent classes of disorder, but some
commonalities. For example, the polyproline type II confor-
mation is very often observed by spectroscopy when studying
IUPs or unfolded proteins [21,22] and such segments seem to
play biological roles in proteins like the synucleins [23].
Methods to predict IUPs are now relatively mature. Proﬁt-
ing from decades of experience in predicting other structural
details (e.g. a-helices and b-strands) many new methods have
appeared in the past ﬁve years [24–32], and these work with
impressive accuracy. As mentioned above, they are now suﬃ-
ciently accurate to allow detailed investigations of the nature
of disorder across whole proteomes.5. Towards potential therapies
IUPs have also, to some extent, provided interesting possi-
bilities for therapeutic intervention. When IUPs form interac-
tions, they very often do this by binding within a shallow
groove inside a globular protein or domain. This type of inter-
action is often much more chemically tractable than those
mediated by large interfaces at the junction of two globular
proteins, and indeed at least half of the recent successes in ﬁnd-
ing compounds to target interactions have been designed or
discovered around IUP binding regions [33], and nearly all
of these are also short linear motif containing regions [34].
The classic example is that of the nutlins, cancer drugs that
act by blocking the interactions between p53 and MDM2
(e.g. see [35]), which frees more of p53 to perform its functions
in apoptosis following DNA damage. However, other exam-
ples exist (e.g. see [34]) and more are surely just around the cor-
ner. Targeting these types of interactions chemically opens
many new doors in terms of subtler regulation, novel chemistry
and better speciﬁcity for new lead molecules.6. No longer a disordered community
Probably the most encouraging recent development has been
the recognition that those studying disorder actually form a
coherent, though diverse, community. As last years EMBO
workshop in Budapest showed, there are ever more Rule of
3 converts wanting to understand and exploit the careful dis-
orderliness that is now clearly no longer in question.
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